Prospective Cohort Study of Severe Bronchiolitis and Risk of Recurrent Wheezing

严重细支气管炎和反复喘息风险的前瞻性队列研究

基本信息

  • 批准号:
    8531845
  • 负责人:
  • 金额:
    $ 97.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-01 至 2016-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Bronchiolitis is the most common cause of infant hospitalization in the US. Small cohort studies (n=51 to 206) suggest that 20-60% of children with severe bronchiolitis (as defined by the need for hospitalization) will develop recurrent wheezing of childhood. Despite this strong association, it remains unclear which children with severe bronchiolitis will develop recurrent wheezing. The proposed prospective multicenter cohort study has 3 specific aims to address this knowledge gap: 1) To examine the association between infectious etiology, illness severity, and CCL5 level and the development of recurrent wheezing by age 3 years. 2) To examine the association between the child's level of serum 25-hydroxyvitamin D [25(OH)D] and recurrent wheezing. 3) To combine these clinical and laboratory data to create a state-of-the-art childhood wheezing index (WIND) to identify children with severe bronchiolitis who are at higher risk of developing recurrent wheezing. This index would identify who might benefit from initiation of inhaled corticosteroids or other asthma control measures, as recommended by the 2007 NIH asthma guidelines. The research team is comprised of NIH-funded researchers who have led many multicenter studies in this area. Over a 2-year period, researchers at 10 hospitals will enroll 1,000 children age <1 year with severe bronchiolitis. Data collection for this cohort will include diaries, biannual interviews, and an annual review of relevant medical records. The study will use the Emergency Medicine Network, a clinical research collaboration that has completed >60 multicenter studies focusing on respiratory emergencies and public health. Site investigators will collect nasopharyngeal and blood samples; demographic, birth, nutritional, family, and environmental information; and clinical data from the parents and from primary care, emergency department, and inpatient settings. The study will have 80% power to detect a 1.3- to 1.8-fold difference in the development of recurrent wheezing for comparisons of children with rhinovirus bronchiolitis (vs. RSV or other pathogens), admitted to the intensive care unit (vs. regular ward), and with detectable (vs. not detectable) CCL5 in nasopharyngeal aspirate. Treating 25(OH)D as a continuous variable, the study will have 80% power to detect a 1.3-fold increase in the odds of recurrent wheezing for a 1 SD (19 nmol/L) increase in 25(OH)D. Study investigators estimate that WIND will have a positive predictive value of e85% to identify children with severe bronchiolitis who will develop recurrent wheezing. The study matches well with the 2009 NIH strategic plan for pediatric respiratory research, and has major public health implications.
描述(由申请人提供):细支气管炎是美国婴儿住院的最常见原因。小型队列研究(n=51 - 206)表明,20-60%的严重毛细支气管炎(定义为需要住院治疗)儿童会出现儿童期反复喘息。尽管有这种强烈的相关性,但仍不清楚哪些严重毛细支气管炎儿童会发生反复喘息。拟定的前瞻性多中心队列研究有3个具体目的来解决这一知识缺口:1)检查感染病因、疾病严重程度和CCL 5水平与3岁时复发性喘息发生之间的相关性。2)探讨儿童血清25-羟维生素D [25(OH)D]水平与反复喘息的关系。3)结合联合收割机这些临床和实验室数据,建立一个最先进的儿童喘息指数(WIND),以确定患有严重毛细支气管炎的儿童谁是复发性喘息的风险较高。该指数将确定谁可能受益于开始吸入皮质类固醇或其他哮喘控制措施,如2007年NIH哮喘指南所建议的。该研究小组由NIH资助的研究人员组成,他们在该领域进行了许多多中心研究。在2年的时间里,10家医院的研究人员将招募1,000名年龄<1岁的严重细支气管炎儿童。该队列的数据收集将包括日记、一年两次的访谈和对相关医疗记录的年度审查。这项研究将使用急诊医学网络,这是一个临床研究合作组织,已经完成了60多项多中心研究,重点是呼吸系统急诊和公共卫生。研究中心研究者将收集鼻咽和血液样本;人口统计学、出生、营养、家庭和环境信息;以及来自父母和初级保健、急诊科和住院机构的临床数据。该研究将有80%的把握度检测到复发性喘息发生的1.3- 1.8倍差异,以比较患有鼻病毒细支气管炎(与RSV或其他病原体)、入住重症监护室(与普通病房)和鼻咽抽吸物中可检测到(与不可检测到)CCL 5的儿童。将25(OH)D作为连续变量处理,研究将有80%的把握度检测到25(OH)D增加1 SD(19 nmol/L),喘息复发的几率增加1.3倍。研究人员估计,WIND将有85%的阳性预测值,以确定儿童严重毛细支气管炎谁将发展为复发性喘息。这项研究与2009年NIH儿科呼吸研究战略计划非常吻合,并具有重大的公共卫生意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CARLOS A. CAMARGO其他文献

CARLOS A. CAMARGO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CARLOS A. CAMARGO', 18)}}的其他基金

Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort
细支气管炎和 6 岁哮喘表型期间的鼻 microRNA:MARC-35 队列
  • 批准号:
    10267407
  • 财政年份:
    2020
  • 资助金额:
    $ 97.49万
  • 项目类别:
Host genetics, early-life microbiome, and childhood asthma: MARC-43 Boston
宿主遗传学、生命早期微生物组和儿童哮喘:MARC-43 波士顿
  • 批准号:
    10742124
  • 财政年份:
    2016
  • 资助金额:
    $ 97.49万
  • 项目类别:
Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort
细支气管炎和 6 岁哮喘表型期间的鼻 microRNA:MARC-35 队列
  • 批准号:
    9215155
  • 财政年份:
    2016
  • 资助金额:
    $ 97.49万
  • 项目类别:
Airway microbiome and age 6y asthma phenotypes in 2 diverse multicenter cohorts
2 个不同多中心队列中的气道微生物组和 6 岁哮喘表型
  • 批准号:
    10242707
  • 财政年份:
    2016
  • 资助金额:
    $ 97.49万
  • 项目类别:
Airway microbiome and age 6y asthma phenotypes in 2 diverse multicenter cohorts
2 个不同多中心队列中的气道微生物组和 6 岁哮喘表型
  • 批准号:
    10012789
  • 财政年份:
    2016
  • 资助金额:
    $ 97.49万
  • 项目类别:
Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort
细支气管炎和 6 岁哮喘表型期间的鼻 microRNA:MARC-35 队列
  • 批准号:
    10062795
  • 财政年份:
    2016
  • 资助金额:
    $ 97.49万
  • 项目类别:
Comparative Effectiveness Research on Hospital Readmissions for COPD
慢性阻塞性肺病再入院的比较效果研究
  • 批准号:
    9768958
  • 财政年份:
    2015
  • 资助金额:
    $ 97.49万
  • 项目类别:
Comparative Effectiveness Research on Hospital Readmissions for COPD
慢性阻塞性肺病再入院的比较效果研究
  • 批准号:
    8885175
  • 财政年份:
    2015
  • 资助金额:
    $ 97.49万
  • 项目类别:
Comparative Effectiveness Research on Hospital Readmissions for COPD
慢性阻塞性肺病再入院的比较效果研究
  • 批准号:
    9147581
  • 财政年份:
    2015
  • 资助金额:
    $ 97.49万
  • 项目类别:
Comparative Effectiveness Research on Hospital Readmissions for COPD
慢性阻塞性肺病再入院的比较效果研究
  • 批准号:
    9349489
  • 财政年份:
    2015
  • 资助金额:
    $ 97.49万
  • 项目类别:

相似海外基金

Plasma 25-Hydroxyvitamin D Concentration and Incident Risk of Dementia: a Case-cohort Study
血浆 25-羟基维生素 D 浓度和痴呆症事件风险:病例队列研究
  • 批准号:
    23K19881
  • 财政年份:
    2023
  • 资助金额:
    $ 97.49万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Association between serum 25-hydroxyvitamin D and endothelium dysfunction in Japanese population
日本人群血清 25-羟基维生素 D 与内皮功能障碍之间的关联
  • 批准号:
    19K21451
  • 财政年份:
    2018
  • 资助金额:
    $ 97.49万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
A prospective study about association between 25-hydroxyvitamin D and cognitive decline and development of lifestyle-related diseases.
一项关于 25-羟基维生素 D 与认知能力下降和生活方式相关疾病发展之间关系的前瞻性研究。
  • 批准号:
    17K09121
  • 财政年份:
    2017
  • 资助金额:
    $ 97.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Direct effects of 25-hydroxyvitamin D on renal fibrosis
25-羟基维生素 D 对肾纤维化的直接影响
  • 批准号:
    26461227
  • 财政年份:
    2014
  • 资助金额:
    $ 97.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Pooled Analysis of 25-hydroxyvitamin D and Colorectal Cancer Survival
25-羟基维生素 D 与结直肠癌生存的汇总分析
  • 批准号:
    8773987
  • 财政年份:
    2014
  • 资助金额:
    $ 97.49万
  • 项目类别:
C-3 alpha epimer of 25-hydroxyvitamin D origin and effects on growing bone
25-羟基维生素 D 来源的 C-3 α 差向异构体及其对骨骼生长的影响
  • 批准号:
    447751-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 97.49万
  • 项目类别:
    University Undergraduate Student Research Awards
Health service utilization, vitamin D supplementation and 25-hydroxyvitamin D levels in young children
幼儿保健服务利用、维生素 D 补充和 25-羟基维生素 D 水平
  • 批准号:
    307836
  • 财政年份:
    2013
  • 资助金额:
    $ 97.49万
  • 项目类别:
    Studentship Programs
C-3 alpha epimer of 25-hydroxyvitamin D origin and effects on growing bone
25-羟基维生素 D 来源的 C-3 α 差向异构体及其对骨骼生长的影响
  • 批准号:
    447773-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 97.49万
  • 项目类别:
    University Undergraduate Student Research Awards
Amelioration of Vesicant-Induced Skin Injury by High Dose 25-Hydroxyvitamin D
高剂量 25-羟基维生素 D 改善出疱剂引起的皮肤损伤
  • 批准号:
    8722316
  • 财政年份:
    2012
  • 资助金额:
    $ 97.49万
  • 项目类别:
Amelioration of Vesicant-Induced Skin Injury by High Dose 25-Hydroxyvitamin D
高剂量 25-羟基维生素 D 改善出疱剂引起的皮肤损伤
  • 批准号:
    8333049
  • 财政年份:
    2012
  • 资助金额:
    $ 97.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了